Expanding Oncovia™: New Research & Clinical Trials At Zenovara Pharmaceuticals, we are committed to continuous innovation in cancer treatment. Oncovia™ is just the beginning—our research pipeline is focused on expanding indications, enhancing drug efficacy, and exploring next-generation combination therapies. • Regulatory submissions in 10+ new countries by next year. • Affordable treatment programs for low-income regions. • Collaboration with top cancer research institutions to accelerate discoveries. • Phase III Trials for Additional Indications • Evaluating Oncovia™ in combination with immunotherapy. • Studying efficacy in EGFR-mutant pancreatic tumors. • Investigating ability to cross the blood-brain barrier.